封面
市场调查报告书
商品编码
1602656

阿尔法发射核素市场:依放射性核种类型、应用划分 - 2025-2030 年全球预测

Alpha Emitters Market by Radionuclide Type (Actinium-225, Americium-241, Astatine-211), Application (Industrial, Medical) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年阿尔法发射核种市场价值为8.8695亿美元,预计到2024年将达到10.6244亿美元,复合年增长率为20.18%,到2030年将达到32.1195亿美元。

α发射核素是一类发射α粒子的放射性药物,主要用于治疗某些癌症,因为它们可以向肿瘤输送高剂量,而对周围健康组织的影响最小。由于癌症仍然是全球健康的一个主要挑战,由于癌症盛行率的增加、核医学的进步以及向个人化医疗的转变,α发射核素的市场正在经历必要的扩张。特别是,这些发送器已应用于治疗多发性骨髓瘤、非何杰金氏淋巴瘤和前列腺癌,最终使用领域涵盖医院、癌症治疗中心和研究机构。市场受到医疗保健支出增加、技术进步以及政府加大癌症治疗措施等因素的影响。然而,鑑于对先进癌症治疗的需求迅速增加和法律规范的改善,新兴市场也存在潜在的机会。投资新的α发射药物的研发以及与医疗机构合作对于公司利用这些机会至关重要。儘管存在这些机会,但市场仍面临严格的监管要求、高生产和研究成本以及低可见度和可用性等限制,特别是在新兴市场。也存在一些挑战,例如需要专门的基础设施和技术人员来安全处理放射性材料。为了克服这些障碍,公司正在开拓更有效的输送系统,以提高α发射核素的治疗指数,改进同位素生产技术,并与生物技术公司合作加快测试和市场进入,重点应放在创新上,例如促进伙伴关係。市场竞争激烈且不断发展,未来前景充满可能性,重点是创新治疗方法和扩大应用范围。

主要市场统计
基准年[2023] 88695万美元
预测年份 [2024] 1,062,440,000 美元
预测年份 [2030] 3,211,950,000 美元
复合年增长率(%) 20.18%

市场动态:快速发展的阿尔法发射核素市场的关键市场洞察

供需的动态交互作用正在改变α发射核素市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心臟疾病和癌症患者增加
    • 提高人们对目标阿尔法发射体潜在好处的认识
    • α发射核种在工业领域的新用途
  • 市场限制因素
    • α发射核素的製造成本高
  • 市场机会
    • 开始癌症治疗的新临床试验活动
    • 持续进行研发活动,开拓α发射核素的新应用领域
  • 市场挑战
    • α发射核素的复杂处理与安全风险

波特五力:驾驭阿尔法核种市场的策略工具

波特的五力架构是了解阿尔法发射核种市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解阿尔法发射核种市场的外部影响

外部宏观环境因素在塑造α发射核素市场表现动态方面发挥至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解α发射核素市场的竞争状况

对阿尔法发射核素市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵α发射核种市场供应商的绩效评估

FPNV定位矩阵是评估α发射核种市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议,为阿尔法发射核种市场的成功指明道路

对于旨在加强在全球市场的影响力的公司来说,对α发射核素市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心臟病和癌症患者数量增加
      • 提高人们对目标阿尔法发射体潜在好处的认识
      • α发射核种在工业领域的新用途
    • 抑制因素
      • α发射核素的生产成本较高。
    • 机会
      • 癌症治疗新临床试验活动的出现
      • 持续进行研发活动,开拓α发射核素的新应用领域
    • 任务
      • α发射核素的复杂处理与安全风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以放射性核种类型分類的α发射核素市场

  • 锕225
  • 镅241
  • 砈-211
  • 钸239
  • 镭226
  • 铀238

第七章 阿尔法发射核种市场:依应用

  • 产业
  • 药品
    • 骨转移
    • 内分泌肿瘤
    • 卵巢癌
    • 胰臟癌
    • 摄护腺癌

第八章美洲阿尔法核素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区α排放核素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲α排放核素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Actinium Pharmaceuticals, Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Bracco SpA
  • Cardinal Health, Inc.
  • Eckert & Ziegler
  • Fusion Pharmaceuticals Inc.
  • Ionetix Corporation
  • Niowave Inc.
  • Orano Group
  • RadioMedix, Inc.
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited
Product Code: MRR-742BD517A934

The Alpha Emitters Market was valued at USD 886.95 million in 2023, expected to reach USD 1,062.44 million in 2024, and is projected to grow at a CAGR of 20.18%, to USD 3,211.95 million by 2030.

Alpha emitters are a category of radiopharmaceuticals that release alpha particles, primarily used in the treatment of certain cancers due to their ability to deliver highly concentrated doses to tumors with minimal impact on surrounding healthy tissues. As cancer continues to be a significant global health challenge, the market for alpha emitters is seeing a necessary expansion, driven by the increasing prevalence of cancer, advancements in nuclear medicine, and the transition towards personalized medicine. Notably, these emitters are being applied in the treatment of multiple myeloma, non-Hodgkin's lymphoma, and prostate cancer, with end-use sectors spanning hospitals, cancer treatment centers, and research institutes. The market is influenced by factors such as rising healthcare spending, technological advancement, and increased government initiatives for cancer treatment. However, potential opportunities exist in emerging markets due to the burgeoning need for advanced cancer treatments and supportive regulatory frameworks. For companies to capitalize on these opportunities, investments in R&D for new alpha-emitting drugs and collaborations with healthcare institutions can be pivotal. Despite these opportunities, the market faces limitations such as stringent regulatory requirements, high costs of production and research, and limited awareness and accessibility, especially in developing regions. Challenges also include the need for specialized infrastructure and skilled personnel to handle these radioactive substances safely. To overcome these hurdles, companies should focus on innovations, such as developing more effective delivery systems to enhance the therapeutic index of alpha emitters, improving isotopic production technologies, and fostering partnerships with biotechnology firms to expedite trials and market entry. The market is highly competitive and evolving, with a push towards innovative treatment methodologies and expanding applicability scopes promising a future vibrant with possibilities.

KEY MARKET STATISTICS
Base Year [2023] USD 886.95 million
Estimated Year [2024] USD 1,062.44 million
Forecast Year [2030] USD 3,211.95 million
CAGR (%) 20.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alpha Emitters Market

The Alpha Emitters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of patients with cardiac and cancer ailments
    • Increased awareness of potential benefits of targeted alpha emitter
    • Emerging use of alpha emitters in industrial sectors
  • Market Restraints
    • High cost of production of alpha emitters
  • Market Opportunities
    • Emerging new clinical trial activities for cancer treatment
    • Ongoing R&D activities for exploring new application areas of alpha emitters
  • Market Challenges
    • Complex handling and safety hazards of alpha emitters

Porter's Five Forces: A Strategic Tool for Navigating the Alpha Emitters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alpha Emitters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alpha Emitters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alpha Emitters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alpha Emitters Market

A detailed market share analysis in the Alpha Emitters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alpha Emitters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alpha Emitters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alpha Emitters Market

A strategic analysis of the Alpha Emitters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alpha Emitters Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Alpha Tau Medical Ltd., Bayer AG, Bracco S.p.A., Cardinal Health, Inc., Eckert & Ziegler, Fusion Pharmaceuticals Inc., Ionetix Corporation, Niowave Inc., Orano Group, RadioMedix, Inc., Siemens Healthineers, and Telix Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Alpha Emitters Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Radionuclide Type, market is studied across Actinium-225, Americium-241, Astatine-211, Plutonium-239, Radium-226, and Uranium-238.
  • Based on Application, market is studied across Industrial and Medical. The Medical is further studied across Bone Metastasis, Endocrine Tumors, Ovarian Cancer, Pancreatic Cancer, and Prostate Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of patients with cardiac and cancer ailments
      • 5.1.1.2. Increased awareness of potential benefits of targeted alpha emitter
      • 5.1.1.3. Emerging use of alpha emitters in industrial sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of alpha emitters
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging new clinical trial activities for cancer treatment
      • 5.1.3.2. Ongoing R&D activities for exploring new application areas of alpha emitters
    • 5.1.4. Challenges
      • 5.1.4.1. Complex handling and safety hazards of alpha emitters
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alpha Emitters Market, by Radionuclide Type

  • 6.1. Introduction
  • 6.2. Actinium-225
  • 6.3. Americium-241
  • 6.4. Astatine-211
  • 6.5. Plutonium-239
  • 6.6. Radium-226
  • 6.7. Uranium-238

7. Alpha Emitters Market, by Application

  • 7.1. Introduction
  • 7.2. Industrial
  • 7.3. Medical
    • 7.3.1. Bone Metastasis
    • 7.3.2. Endocrine Tumors
    • 7.3.3. Ovarian Cancer
    • 7.3.4. Pancreatic Cancer
    • 7.3.5. Prostate Cancer

8. Americas Alpha Emitters Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Alpha Emitters Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Alpha Emitters Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actinium Pharmaceuticals, Inc.
  • 2. Alpha Tau Medical Ltd.
  • 3. Bayer AG
  • 4. Bracco S.p.A.
  • 5. Cardinal Health, Inc.
  • 6. Eckert & Ziegler
  • 7. Fusion Pharmaceuticals Inc.
  • 8. Ionetix Corporation
  • 9. Niowave Inc.
  • 10. Orano Group
  • 11. RadioMedix, Inc.
  • 12. Siemens Healthineers
  • 13. Telix Pharmaceuticals Limited

LIST OF FIGURES

  • FIGURE 1. ALPHA EMITTERS MARKET RESEARCH PROCESS
  • FIGURE 2. ALPHA EMITTERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALPHA EMITTERS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ASTATINE-211, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLUTONIUM-239, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-226, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY URANIUM-238, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 150. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023